Bharat Parenterals Equity 2024

Equity Details

Analyzing Bharat Parenterals's Equity

Bharat Parenterals's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bharat Parenterals's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bharat Parenterals's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bharat Parenterals's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bharat Parenterals’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bharat Parenterals Stock

What is the equity of Bharat Parenterals this year?

Bharat Parenterals has equity of 1.97 B INR this year.

What was the equity of Bharat Parenterals compared to the previous year?

The equity of Bharat Parenterals has increased/decreased by 18.96% increased compared to the previous year.

What impact does a high equity have on investors of Bharat Parenterals?

A high equity is advantageous for investors of Bharat Parenterals as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Bharat Parenterals?

A low equity can be a risk for investors of Bharat Parenterals, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Bharat Parenterals affect the company?

An increase in equity of Bharat Parenterals can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Bharat Parenterals affect the company?

A reduction in equity of Bharat Parenterals can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Bharat Parenterals?

Some factors that can affect the equity of Bharat Parenterals include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Bharat Parenterals so important for investors?

The equity of Bharat Parenterals is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Bharat Parenterals take to change the equity?

To change equity, Bharat Parenterals can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Bharat Parenterals pay?

Over the past 12 months, Bharat Parenterals paid a dividend of 0.75 INR . This corresponds to a dividend yield of about 0.05 %. For the coming 12 months, Bharat Parenterals is expected to pay a dividend of 0.75 INR.

What is the dividend yield of Bharat Parenterals?

The current dividend yield of Bharat Parenterals is 0.05 %.

When does Bharat Parenterals pay dividends?

Bharat Parenterals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bharat Parenterals?

Bharat Parenterals paid dividends every year for the past 0 years.

What is the dividend of Bharat Parenterals?

For the upcoming 12 months, dividends amounting to 0.75 INR are expected. This corresponds to a dividend yield of 0.05 %.

In which sector is Bharat Parenterals located?

Bharat Parenterals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bharat Parenterals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bharat Parenterals from 10/29/2023 amounting to 0.75 INR, you needed to have the stock in your portfolio before the ex-date on 9/25/2023.

When did Bharat Parenterals pay the last dividend?

The last dividend was paid out on 10/29/2023.

What was the dividend of Bharat Parenterals in the year 2023?

In the year 2023, Bharat Parenterals distributed 0 INR as dividends.

In which currency does Bharat Parenterals pay out the dividend?

The dividends of Bharat Parenterals are distributed in INR.